Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1954 2
1955 1
1956 1
1957 2
1958 1
1964 2
1969 1
1974 3
1975 4
1976 4
1979 2
1980 1
1981 2
1982 3
1983 6
1984 11
1985 10
1986 18
1987 11
1988 15
1989 26
1990 32
1991 29
1992 52
1993 40
1994 39
1995 27
1996 55
1997 48
1998 63
1999 62
2000 89
2001 65
2002 77
2003 93
2004 96
2005 90
2006 110
2007 114
2008 142
2009 123
2010 163
2011 153
2012 178
2013 187
2014 216
2015 242
2016 247
2017 252
2018 295
2019 318
2020 428
2021 474
2022 481
2023 223

Text availability

Article attribute

Article type

Publication date

Search Results

4,884 results

Results by year

Filters applied: . Clear all
Page 1
The complexity of Alzheimer's disease: an evolving puzzle.
Ferrari C, Sorbi S. Ferrari C, et al. Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21. Physiol Rev. 2021. PMID: 33475022 Free article. Review.
The history of Alzheimer's disease (AD) started in 1907, but we needed to wait until the end of the century to identify the components of pathological hallmarks and genetic subtypes and to formulate the first pathogenic hypothesis. Thanks to biomarkers and ne …
The history of Alzheimer's disease (AD) started in 1907, but we needed to wait until the end of the century to identify …
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.
Qiu C, Kivipelto M, von Strauss E. Qiu C, et al. Dialogues Clin Neurosci. 2009;11(2):111-28. doi: 10.31887/DCNS.2009.11.2/cqiu. Dialogues Clin Neurosci. 2009. PMID: 19585947 Free PMC article. Review.
More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregiv …
More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In bo …
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.
Atri A. Atri A. Med Clin North Am. 2019 Mar;103(2):263-293. doi: 10.1016/j.mcna.2018.10.009. Med Clin North Am. 2019. PMID: 30704681 Free article. Review.
Alzheimer's disease (AD) care requires timely diagnosis and multidisciplinary management. ...AD biopathologic processes develop over decades before symptoms manifest; this period is increasingly targeted in research as an opportunity to best delay or p …
Alzheimer's disease (AD) care requires timely diagnosis and multidisciplinary management. ...AD biopathologic processes …
Rodent models of neuroinflammation for Alzheimer's disease.
Nazem A, Sankowski R, Bacher M, Al-Abed Y. Nazem A, et al. J Neuroinflammation. 2015 Apr 17;12:74. doi: 10.1186/s12974-015-0291-y. J Neuroinflammation. 2015. PMID: 25890375 Free PMC article. Review.
Alzheimer's disease remains incurable, and the failures of current disease-modifying strategies for Alzheimer's disease could be attributed to a lack of in vivo models that recapitulate the underlying etiology of late-onset Alzh …
Alzheimer's disease remains incurable, and the failures of current disease-modifying strategies for Alzheimer …
Alzheimer's disease: risk factors and potentially protective measures.
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Silva MVF, et al. J Biomed Sci. 2019 May 9;26(1):33. doi: 10.1186/s12929-019-0524-y. J Biomed Sci. 2019. PMID: 31072403 Free PMC article. Review.
Alzheimer's disease (AD) is the most common type of dementia and typically manifests through a progressive loss of episodic memory and cognitive function, subsequently causing language and visuospatial skills deficiencies, which are often accompanied b …
Alzheimer's disease (AD) is the most common type of dementia and typically manifests through a progressive loss …
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
Ossenkoppele R, van der Kant R, Hansson O. Ossenkoppele R, et al. Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25. Lancet Neurol. 2022. PMID: 35643092 Review.
BACKGROUND: Deposition of tau aggregates is a pathological hallmark of Alzheimer's disease that is closely linked both spatially and temporally to emergence of neurodegeneration and manifestation of clinical symptoms. ...The advent of cost-effective an …
BACKGROUND: Deposition of tau aggregates is a pathological hallmark of Alzheimer's disease that is closely linked both …
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis.
Liss JL, Seleri Assunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Liss JL, et al. J Intern Med. 2021 Aug;290(2):310-334. doi: 10.1111/joim.13244. Epub 2021 Mar 31. J Intern Med. 2021. PMID: 33458891 Free PMC article. Review.
The critical role of primary care clinicians (PCCs) in Alzheimer's disease (AD) prevention, diagnosis and management must evolve as new treatment paradigms and disease-modifying therapies (DMTs) emerge. Our understanding of AD has grown substantially: …
The critical role of primary care clinicians (PCCs) in Alzheimer's disease (AD) prevention, diagnosis and management mu …
Visual system manifestations of Alzheimer's disease.
Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Kusne Y, et al. Acta Ophthalmol. 2017 Dec;95(8):e668-e676. doi: 10.1111/aos.13319. Epub 2016 Nov 19. Acta Ophthalmol. 2017. PMID: 27864881 Free article. Review.
Alzheimer's disease (AD) is an increasingly common disease with massive personal and economic costs. ...
Alzheimer's disease (AD) is an increasingly common disease with massive personal and economic costs. ...
Retinal manifestations of Alzheimer's disease.
Dehabadi MH, Davis BM, Wong TK, Cordeiro MF. Dehabadi MH, et al. Neurodegener Dis Manag. 2014;4(3):241-52. doi: 10.2217/nmt.14.19. Neurodegener Dis Manag. 2014. PMID: 25095818 Review.
Alzheimer's disease (AD) is neurodegenerative condition and most common cause of dementia worldwide. ...Due to the eye's unique optical properties allowing noninvasive in vivo imaging, the retina could provide a window for the early diagnosis and monit …
Alzheimer's disease (AD) is neurodegenerative condition and most common cause of dementia worldwide. ...Due to the eye' …
4,884 results